Total Raised

$1.7M

Investors Count

1

Deal Terms

1

Funding, Valuation & Revenue

1 Fundings

AdExtent has raised $1.7M over 1 rounds.

AdExtent's latest funding round was a Series A for $1.7M on January 1, 2008.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/1/2008

Series A

$1.7M

$XXM

0

FY undefined

Date

1/1/2008

Round

Series A

Amount

$1.7M

Investors

Valuation

$XXM

Revenue

0

FY undefined

Sources

Start free trial
New call-to-action

AdExtent Deal Terms

1 Deal Term

AdExtent's deal structure is available for 1 funding round, including their Series A from January 01, 2008.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

AdExtent Investors

1 Investors

AdExtent has 1 investors. Giza Venture Capital invested in AdExtent's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/1/2008

1/1/2008

1
Series A

Venture Capital

Israel

First funding

1/1/2008

Last Funding

1/1/2008

Investor

Rounds

1
Series A

Board Seats

Type

Venture Capital

Location

Israel

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.